688185 CanSino Biologics Inc.
- 48.78
- -0.07-0.14%
CanSino Biologics Inc. News
Materials for the 2023 Annual Shareholders Meeting.
Announcement from Cansino Biologics Inc. listed in Hong Kong.
Investor relations activity record for May 2024.
Announcement on the Resignation of Non-Executive Directors and Election of Non-Executive Directors and Members of the Special Committee on the Adjustment of the Board
Notice on convening the 2023 Annual General Meeting of Shareholders
Conxino H Share Announcement
Conxino H Share Announcement
Investor Relations Activity Schedule for April 2024
Conxino H Share Announcement
Notice of Response to the Information Disclosure Regulatory Inquiry Letter on the 2023 Annual Report
Deloitte Huayong Certified Public Accountants (Special General Partnership) Response to the Information Disclosure Regulatory Inquiry Letter on Cansino Biotech's 2023 Annual Report
CITIC Securities Co., Ltd.'s verification opinion on the response to the regulatory inquiry letter on the information disclosure of the 2023 annual report of Cansino Biotech Co., Ltd.
Announcement of Resolutions of the Third Meeting of the Third Board of Supervisors
2024 First Quarter Report
Announcement on signing product transfer and technology licensing agreements and related transactions
Resolutions of the first meeting of the 3rd Special Meeting of Independent Directors of the Board of Directors
Announcement on the approval notice for the freeze-dried Haemophilus influenzae type b conjugate vaccine
Voluntary Disclosure Notice on Positive Preliminary Phase I Clinical Results of the Recombinant Pneumococcal Protein Vaccine
Conxino H Share Announcement
CITIC Securities Co., Ltd.'s 2023 Continuous Supervision Work Site Inspection Report on Cansino Biotech Co., Ltd.
Analysis
Price Target
No Data
